Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)

Widespread prostate-specific antigen (PSA) testing notably increased the number of prostate cancer (PCa) diagnoses. However, about 30% of these patients have low-risk tumors that are not lethal and remain asymptomatic during their lifetime. Overtreatment of such patients may reduce quality of life a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferro, Matteo, Ungaro, Paola, Cimmino, Amelia, Lucarelli, Giuseppe, Busetto, Gian Maria, Cantiello, Francesco, Damiano, Rocco, Terracciano, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485970/
https://www.ncbi.nlm.nih.gov/pubmed/28555004
http://dx.doi.org/10.3390/ijms18061146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485970/
https://www.ncbi.nlm.nih.gov/pubmed/28555004
http://dx.doi.org/10.3390/ijms18061146

Ejemplares similares